Skip to main content
. 2017 Sep 7;16(6):1276–1287. doi: 10.1111/acel.12661

Table 1.

Clinical data of the study participants

Premenopausal n = 6 Postmenopausal nonusers n = 9 Postmenopausal HRT users n = 9
Age (years) 31.8 ± 1.8 57.3 ± 2.2 57.3 ± 2.2
Health and lifestyle variables
Number of chronic diseases or conditions
Allergy (n) 4 2 1
Musculoskeletal problems (n) 4 4 3
Migraine (n) 3 1 0
Cancer history (n) 0 1 0
Hypertension with medication (n) 0 4 5
Current smokers (n) 2 1 1
Physical activity
Sedentary (n) 0 1 1
Moderately active (n) 3 3 3
Active (n) 3 5 4
Gynecological data
Age at first menstruation (years) 13.3 ± 2.0 12.9 ± 1.4 12.6 ± 1.0
Age at last menstruation (years) Still menstruating 48.7 ± 4.2 50.7 ± 2.0
Number of participants with regular menstrual cycle (n) 6 No cycle No cycle
Mean length of the cycle (days) 28.3
Number of participants been pregnant (n) 4 8 7
Number of pregnancies per participant (n) 0–3 0–3 0–3
Number of participants having used hormonal contraceptive during past 10 years; but not within last 5 years (n) 3 1 1
Number of participants with ovariectomy and/or hysterectomy (n) 0 1 3
Number of participants reporting menopausal symptoms 0 9 7
Use of HRT Never Never Currently
Duration of HRT use (years) 7.3 ± 3.3
Number of E2‐HRT users (n) 3
Number of E2+progestogen‐HRT users (n) 3
Number of Tib‐HRT users 3

Data are presented either as mean ± standard deviation or as total number of participants. HRT = hormone replacement therapy, E2 = 17β‐estradiol, Tib = tibolone.